Literature DB >> 8534126

Ultrastructural localization of binding sites of sera from patients with linear IgA bullous dermatosis.

C Kowalewski1, M Haftek, S Jablonska, D Schmitt.   

Abstract

The localization of the antigen recognized by IgA basement membrane zone (BMZ) antibodies from patients with linear IgA bullous dermatosis (LABD) has not been established. The aim of our study was to find out the binding sites for IgA-BMZ antibodies in LABD in adults and children and, for comparison, the binding sites for IgA antibodies in IgA cicatricial pemphigoid (IgA-CP). Our series comprised 21 sera from adult LABD, 4 sera from childhood LABD, and 2 sera from IgA-CP. The studies were performed using the sodium chloride split-skin method and indirect immunoelectron microscopy (IEM) with the use of the pre-embedding immunoperoxidase technique on two substrates: monkey oesophagus and normal human skin. Of the 27 sera, 24 reacted with the epidermis (19 from adult, 4 from childhood LABD and 1 from IgA-CP) and at the electron microscopic level labelled the upper part of the lamina lucida (LL) and/or hemidesmosomes, and 2 reacted with the dermis (1 from typical adult LABD and 1 from IgA-CP) and labelled the sublamina densa (SLD) region. Two sera were negative in IEM. In conclusion, the study indicated that the localization of the antigens is similar in adult and childhood LABD, and in IgA-CP.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8534126     DOI: 10.1007/bf00371735

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN: 0340-3696            Impact factor:   3.017


  21 in total

1.  Diagnosis of adult linear IgA dermatosis by immunoelectronmicroscopy in 16 patients with linear IgA deposits.

Authors:  C Prost; A C De Leca; P Combemale; B Labeille; N Martin; A Cosnes; J C Guillaume; P Y Venencie; J L Verret; L Dubertret
Journal:  J Invest Dermatol       Date:  1989-01       Impact factor: 8.551

2.  Identification of the cutaneous basement membrane zone antigen and isolation of antibody in linear immunoglobulin A bullous dermatosis.

Authors:  J J Zone; T B Taylor; D P Kadunce; L J Meyer
Journal:  J Clin Invest       Date:  1990-03       Impact factor: 14.808

3.  IgA linear dermatosis of childhood (chronic bullous disease of childhood).

Authors:  T P Chorzelski; S Jablonska
Journal:  Br J Dermatol       Date:  1979-11       Impact factor: 9.302

4.  Immunofluorescence studies in the diagnosis of dermatitis herpetiformis and its differentiation from bullous pemphigoid.

Authors:  T P Chorzelski; E H Beutner; S Jablonska; M Blaszczyk; C Triftshauser
Journal:  J Invest Dermatol       Date:  1971-05       Impact factor: 8.551

5.  The relationship between linear IgA disease and benign mucous membrane pemphigoid.

Authors:  J N Leonard; P Wright; D M Williams; J J Gilkes; G P Haffenden; R M McMinn; L Fry
Journal:  Br J Dermatol       Date:  1984-03       Impact factor: 9.302

6.  Ultrastructural localization of IgA deposits in adult linear IgA disease.

Authors:  J N Leonard; G P Haffenden; N Ring; L Fry
Journal:  J R Soc Med       Date:  1982-04       Impact factor: 5.344

7.  A case of cicatricial pemphigoid or cicatricial linear IgA bullous dermatosis.

Authors:  V Kumar; T Rogozinski; C Yarbrough; E H Beutner; T P Chorzelski
Journal:  J Am Acad Dermatol       Date:  1980-04       Impact factor: 11.527

8.  Linear IgA bullous dermatosis of adults and children: an immunoelectron microscopic study.

Authors:  B Bhogal; F Wojnarowska; R A Marsden; A Das; M M Black; P H McKee
Journal:  Br J Dermatol       Date:  1987-09       Impact factor: 9.302

9.  Immunogold localization of the 97-kD antigen of linear IgA bullous dermatosis (LABD) detected with patients' sera.

Authors:  M Haftek; J J Zone; T B Taylor; C Kowalewski; T P Chorzelski; D Schmitt
Journal:  J Invest Dermatol       Date:  1994-11       Impact factor: 8.551

10.  Differentiating anti-lamina lucida and anti-sublamina densa anti-BMZ antibodies by indirect immunofluorescence on 1.0 M sodium chloride-separated skin.

Authors:  W R Gammon; R A Briggaman; A O Inman; L L Queen; C E Wheeler
Journal:  J Invest Dermatol       Date:  1984-02       Impact factor: 8.551

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.